Related Experiment Videos
Complement activation in infective endocarditis: correlation with extracardiac manifestations and prognosis
I J Messias-Reason1, S Y Hayashi, R M Nisihara
1Laboratory of Immunopathology, Department of Pathology, Clinical Hospital of Federal University of Paraná, Curitiba, Brazil. immunopat@hc.ufpr.br
Clinical and Experimental Immunology
|March 6, 2002
Summary
Infective endocarditis (IE) activates the complement system, a key part of immunity. This study found elevated complement activation products, linked to disease severity and complications, suggesting diagnostic potential for IE biomarkers.
Area of Science:
- Immunology
- Cardiovascular Medicine
- Infectious Diseases
Background:
- Complement activation is crucial for immune response but can cause tissue damage when excessive.
- Infective endocarditis (IE) patients often have high levels of circulating immune complexes (CIC) that activate complement.
- The role of complement activation in IE's extracardiac manifestations and prognosis is not well understood.
Purpose of the Study:
- To investigate complement activation in IE patients.
- To explore correlations between complement activation products and extracardiac manifestations.
- To assess the relationship between complement activation and clinical outcomes in IE.
Main Methods:
- Plasma levels of complement activation products (C3adesArg, SC5b-9, C1rs-C1Inh, C3b(Bb)P, C3d) were measured using ELISA and immunoelectrophoresis.
- C3 and C4 levels were determined by turbidimetry.
- Circulating immune complexes (CIC) were quantified by ELISA.
Main Results:
- IE patients showed significantly elevated levels of C3d, C3adesArg, SC5b-9, and C1rs-C1Inh compared to controls, indicating classical pathway activation.
- Patients with IE had increased CIC levels and reduced C3 levels.
- Elevated C3d and C3adesArg levels correlated with pulmonary manifestations and mortality.
Conclusions:
- The classical complement pathway is activated in IE, likely mediated by CIC.
- C3d and C3adesArg show potential as biomarkers for predicting extracardiac lesions and disease severity in IE.